نتائج البحث - Yi‐Ping Hung

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study

    How different is the care of terminal pancreatic cancer patients in inpatient palliative care units and acute hospital wards? A nationwide population-based study حسب Jack Wang, Chen‐Yi Wu, I-Hsuan Hwang, Chien-Hui Kao, Yi‐Ping Hung, Shinn‐Jang Hwang, Chung–Pin Li

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience

    Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience حسب Wen‐Chi Wu, Tzu-Yuan Lin, Ming‐Huang Chen, Yi‐Ping Hung, Chien‐An Liu, Rheun‐Chuan Lee, Yi‐Hsiang Huang, Yee Chao, San‐Chi Chen

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer

    The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer حسب Cheng‐Yu Tang, Yi‐Ting Lin, Yi‐Chen Yeh, Shin‐Yi Chung, Yu‐Chan Chang, Yi-Ping Hung, San‐Chi Chen, Ming Huang Chen, Nai‐Jung Chiang

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy

    Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy حسب Hsien-Chen Mon, Pei‐Chang Lee, Yi‐Ping Hung, Ya‐Wen Hung, Chi-Jung Wu, Chieh-Ju Lee, Chen‐Ta Chi, I‐Cheng Lee, Ming‐Chih Hou, Yi‐Hsiang Huang

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial

    Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial حسب Jack Wang, Chen‐Yi Wu, Yi-Cheng Yeh, Yi‐Ming Shyr, Yingying Wu, Chen‐Yu Kuo, Yi‐Ping Hung, Ming‐Huang Chen, Wei‐Ping Lee, Jiing‐Chyuan Luo, Yee Chao, Chung–Pin Li

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Immunoprofile of adenosquamous carcinoma in gastric cancer

    Immunoprofile of adenosquamous carcinoma in gastric cancer حسب Cheng-Han Wu, Cheng‐Lun Lai, Chieh‐Lin Jerry Teng, Wen‐Liang Fang, Kuo‐Hung Huang, Anna Fen‐Yau Li, Hung-Yuan Yu, Nai‐Jung Chiang, Yee Chao, Yi‐Ping Hung, Ming‐Huang Chen

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

    Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma حسب Li-Chun Lü, Chiun Hsu, Yu‐Yun Shao, Yee Chao, Chia‐Jui Yen, I‐Lun Shih, Yi‐Ping Hung, Chun‐Jung Chang, Ying‐Chun Shen, Jhe‐Cyuan Guo, Tsung‐Hao Liu, Chih‐Hung Hsu, Ann‐Lii Cheng

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection

    Evolutionary Learning-Derived Clinical-Radiomic Models for Predicting Early Recurrence of Hepatocellular Carcinoma after Resection حسب I‐Cheng Lee, Jo-Yu Huang, Ting‐Chun Chen, Chia-Heng Yen, Nai‐Chi Chiu, Hsuen-En Hwang, Jia-Guan Huang, Chien‐An Liu, Gar‐Yang Chau, Rheun‐Chuan Lee, Yi‐Ping Hung, Yee Chao, Shinn‐Ying Ho, Yi‐Hsiang Huang

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma

    Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma حسب Shin‐Yi Chung, Yi‐Chen Yeh, Chien-Jung Huang, Nai-Jung Chiang, Dennis Shin‐Shian Hsu, Ming‐Hsien Chan, Meng-Lun Lu, Tzu-Sheng Hsu, Yi‐Ping Hung, Chun‐Nan Yeh, Michael Hsiao, Yu‐Chan Chang, Yu‐Chao Wang, Ming‐Huang Chen

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma

    Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma حسب Yuan‐Hung Wu, Yi‐Ping Hung, Nai‐Chi Chiu, Rheun‐Chuan Lee, Chung–Pin Li, Yee Chao, Yi‐Ming Shyr, Shin‐E Wang, Shih‐Chin Chen, Sheng‐Hsuan Lin, Yi‐Hsuan Chen, Yu‐Mei Kang, Shih‐Ming Hsu, Sang‐Hue Yen, Jeng-You Wu, Kuan‐Der Lee, Huey-En Tseng, Jia-Ruey Tsai, Jui‐Hsiang Tang, Jeng‐Fong Chiou, Thierry Burnouf, Yin‐Ju Chen, Peng‐Yuan Wang, Long‐Sheng Lu

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: